Meningeal carcinomatosis as a late complication of brain metastases of epithelial ovarian carcinoma

The brain represents a rare site of metastasis in patients with epithelial ovarian carcinoma (EOC). In recent decades there has been an apparent increase in the number of EOC patients diagnosed with brain metastases, probably as a result of improved prognosis of patients with advanced tumors, but cases of meningeal carcinomatosis complicating EOC remain rare. A patient with Stage III EOC had brain metastases diagnosed 31 months after primary surgery. The isolated brain metastases were controlled with radiosurgery, surgery and chemotherapy. Forty-five months after the diagnosis of brain metastases, meningeal carcinomatosis was diagnosed which led, despite intrathecal therapy, to a fatal outcome. At autopsy, the disease was limited to the central nervous system. Meningeal carcinomatosis may represent a late fatal complication of brain metastases of EOC.

Brain metastasis; Epithelial ovarian carcinoma; Meningeal carcinomatosis

[1] Melichar B., Urminská H., Kohlová T., Nová M., Cesák T.: “Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature”. Gynecol. Oncol., 2004, 94, 367.

[2] van der Ree T.C., Dippel D.W.J., Avezaat C.J.J., Sillevis Smitt P.A.E., Vecht C.J., van den Bent M.J.: “Leptomeningeal metastasis after surgical resection of brain metastases”. J. Neurol. Neurosurg. Psychiatry, 1999, 66, 225.

[3] Lagerwaard F.J., Levendag P.C., Nowak P.J.C.M., Eijkenboom W.M.H., Hanssens P.E.J., Schmitz P.I.M.: “Identification of prognostic factors in patients with brain metastases: A review of 1292 patients”. Int. J. Radiat. Oncol. Biol. Phys., 1999, 43, 795.

[4] Cohen Z.R., Suki D., Weinberg J.S., Marmor E., Lang F.F., Gershenson D.M. et al.: “Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome”. J. Neuro-oncol., 2004, 66, 313.

[5] Khalil A.M., Yamout B.I., Tabbal S.D., Salem Z.M.K., Mroueh A.M.: “Case report and review of literature: leptomeningeal relapse in epithelial ovarian cancer”. Gyn. Oncol., 1994, 54, 227.

[6] Ohta H., Koyama R., Nagai T., Hirayama Y., Saito S., Yonesaka A.: “Meningeal carcinomatosis from an ovarian primary with complete response to adjuvant chemotherapy after cranial irradiation”. Int. J. Clin. Oncol., 2001, 6, 157.

[7] Kosmas C., Tsavaris N.B., Soukoli G., Gouveris P., Tsakonas G., Katselis J., et al. : “Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer”. Med. Oncol., 2005, 22, 123.

[8] Chung P., Allerton R.: “Malignant meningitis secondary to ovarian carcinoma: an unusual occurrence”. Clin. Oncol. (R. Coll. Radiol.), 2001, 13, 112.

[9] Delord J.P., Fizazi K., El Hajj M., Pautier P., Lhomme C.: “Isolated leptomeningeal metastasis from ovarian carcinoma: an unusual event”. Eur. J. Cancer, 1998, 34, 758.

[10] Levy J., Marcus M., Shelef I., Lifshitz T.: “Acute bilateral blindness in meningeal carcinomatosis”. Eye, 2004, 2004, 206.